Table 1. Individual patient data of non-small cell lung cancer harboring oncogenic AKT1 mutations, FGFR3 mutations, EGFR extracellular domain mutations, HER2 extracellular and transmembrane domain mutations, ARAF mutations and NRG1 fusions.

No.	Gene	Mut	Histology	Sex	Age	Smoke	T (cm)	N	Stage
1	AKT1	E17K	AD	F	73	Never	1.5	N0	1a
2	AKT1	E17K	AD	M	30	Never	6	N1	2b
3	AKT1	E17K	AdSqLC	M	60	Ever	1.8	N0	1a
4	AKT1	E17K	AdSqLC	F	62	Never	5	N0	1b
5	AKT1	E17K	SCC	M	50	Ever	5.5	N1	2b
6	FGFR3	S249C	SCC	M	79	Ever	3.2	N0	1b
7	FGFR3	S249C	SCC	M	68	Ever	4.5	N1	2a
8	FGFR3	S249C	SCC	M	64	Ever	6.5	N0	2a
9	FGFR3	S249C	SCC	M	62	Ever	4.5	N0	1b
10	FGFR3	S249C	SCC	M	49	Never	8.0	N0	2b
11	FGFR3	R248C	SCC	M	59	Ever	5.5	N1	2b
12	EGFR	A289D	AD	F	64	Never	3	N0	1a
13	EGFR	R324L	AD	M	74	Ever	4.5	N2	3a
14	HER2	S310Y	AD	F	37	Never	3	N2	3a
15	HER2	V659E	AD	F	62	Never	0.7	N0	1a
16	ARAF	S214C	AD	F	51	Never	2.5	N0	1a
17	NRG1	CD74-NRG1	AD	F	69	Never	0.6	N0	1a
18	NRG1	CD74-NRG1	AD	F	62	Never	2.7	N0	1a

Abbreviations: Mut, mutations; T, tumor size; N, nodal status; AD, adenocarcinoma; AdSqLC, adenosquamous lung carcinoma; SCC, squamous cell carcinoma; F, female; M, male.